News
20hon MSN
New 100-week data from the ongoing Phase I/II study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...
The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...
A Fargo veterinary clinic is reporting an outbreak of canine parvovirus. Prairie Winds Veterinary Center has confirmed cases ...
21h
News-Medical.Net on MSNNew data shows zigakibart sustains proteinuria remission and kidney function in IgA nephropathyNew 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...
The FDA has designated the viral vector rAAVrh74, which Sarepta Therapeutics, Inc. (NASDAQ:SRPT) uses in its gene therapy ...
14h
SurvivorNet on MSNImmunotherapy For Small Cell Lung Cancer: Groundbreaking New Developments Offer Hope To PatientsFor the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...
15h
Great Pet Care on MSNCytopoint vs. Apoquel: Dog Allergy Medicine Comparison GuideIf your dog is suffering from allergies, you’re likely trying to decide between Cytopoint vs Apoquel, the two most commonly prescribed allergy medications for dogs. In this comparison guide, we’ll ...
A retrospective, real-world data analysis from the TriNetX database sought to determine rates of venous thromboembolism and survival outcomes in patients with multiple myeloma who were treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results